Pharmacogenomic Testing
Genetic testing to determine how an individual's genetic makeup affects their response to addiction treatment medications.
Full Definition
Pharmacogenomic testing analyzes genetic variations that influence how patients metabolize and respond to medications commonly used in addiction treatment, including methadone, buprenorphine, and psychiatric medications for co-occurring disorders. Results can guide dosing decisions, medication selection, and monitoring protocols to optimize therapeutic outcomes while minimizing adverse effects. This precision medicine approach is particularly valuable in addiction treatment where medication response varies significantly among individuals. Clinical documentation must appropriately interpret and apply pharmacogenomic results to treatment decisions.
Usage
Usage note: Do not hyphenate; may be abbreviated as PGx testing in clinical shorthand.
In Context
- "Pharmacogenomic testing revealed the patient was a poor metabolizer requiring adjusted methadone dosing." — Clinical genetics report
- "The treatment protocol incorporates pharmacogenomic testing results to optimize medication selection." — Precision medicine documentation